- Assistant Professor
Board Certification
- Internal Medicine
- Internal Medicine - Hematology
- Internal Medicine - Medical Oncology
Training
Medical School- University of Madras
- Bronx Lebanon Hospital Center, NY
- Hematology; Montefiore Medical Center, NY
- Medical Oncology; Mt. Sinai Medical Center, NY
Specialty
- Internal Medicine
Subspecialty
- Hematology, Oncology
Contact Information
Stony Brook Cancer Center
Stony Brook, NY 11794
Ph.: 631-444-2316
Fax:
- Personal Statement
- Honors
- Publications
- Grants/Trials
- For articles published by Dr. Richard, click here
- CLINICAL TRIAL - PRINCIPAL INVESTIGATOR - NATIONAL MARROW DONOR PROGRAM - A Phase II Randomized Clinical Trial Evaluating Neoadjuvant Therapy Regimens with Weekly Paclitaxel
- CLINICAL TRIAL - PRINCIPAL INVESTIGATOR - QUINTILES INCORPORATED - and Neratinib or Trastuzumab Followed by Doxorubicin and Cyclophosphamide with Postoperative Trastuzumab
- CLINICAL TRIAL - PRINCIPAL INVESTIGATOR - NOVARTIS PHARMACEUTICALS CORPORATION - in Women with Locally Advanced Her2-Positive Breast Cancer.
- CLINICAL TRIAL - PRINCIPAL INVESTIGATOR - PFIZER INCORPORATED - An Open-Label, Randomized, Phase 3 Study of Inotuzumab Ozogamicin Administered in Combination with Rituximab Compared to Defined Investigators Choice Therapy in Subjects with Relapsed or Refractory CD22-Positive Aggressive Non-Hodgkin Lymp
- CLINICAL TRIAL - CO-INVESTIGATOR - MERCK AND COMPANY - A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of V212 in Recipients of Autologous Hematopoietic Cell Transplants (HCTs)
- CLINICAL TRIAL - CO-INVESTIGATOR - SUNESIS PHARMACEUTICALS INCORPORATED - A Phase 3, Randomized, Controlled, Double-Blind, Multinational Clinical Study of the Efficacy and Safety of Vosaroxin and Cytarabine Versus Placebo and Cytarabine in Patients with First Relapsed of Refractory Acute Myeloid Leukemia (VALOR)
- CLINICAL TRIAL - CO-INVESTIGATOR - ICON CLINICAL RESEARCH - BMS: Studying Interventions for Managing Patients with Chronic Myeloid Leukemia in Chronic Phase: The 5 Year Prospective Cohort Study (SIMPLICITY)
- CLINICAL TRIAL - CO-INVESTIGATOR - AMGEN INCORPORATED - A Phase I Study Evaluating the Safety,Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered AMG 900 in Adult Subjects with Acute Leukemias and Related Disorders
- CLINICAL TRIAL - CO-INVESTIGATOR - KIADIS PHARMA NETHERLANDS B V - An Open-Label, Uncontrolled, Multicenter, Multinational Study on the Efficacy and Safety of Administration of Donor Lymphocytes Depleted of Alloreactive T-Cells (ATIR), Through the Use of TH9402 and Light Treatment in an Ex Vivo Process, i
- CLINICAL TRIAL - CO-INVESTIGATOR - SCHERING PLOUGH RESEARCH INSTITUTE - Pharmacokinetics, Safety and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1B)
- CLINICAL TRIAL - CO-INVESTIGATOR - THERAKOS INCORPORATED - An International Randomized Controlled Study of Extracorporeal Photopheresis Therapy for the Treatment of Patients with Chronic Graft-versus-Host Disease
- CLINICAL TRIAL - CO-INVESTIGATOR - MERCK SHARP AND DOHME CORPORATION - A Phase III, Randomized, Placebo-Controlled, Clinical Trial t Study the Safety and Efficacy, of V212 in Adult Patients with Solid Tumor or Hematopoietic Malignancy
- CLINICAL TRIAL - CO-INVESTIGATOR - COVANCE - TaiGen: Phase II, Open-Label Study to Evaluate the Safety, Pharmacokinetics, and Hematopoietic Stem Cell Mobilization of TG-0054 Alone or in Combination with G-CSF in Patients with Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin Disease
